Brief: Aurobindo Pharma Posts March-Qtr Consol Net PAT 9.21 Billion Rupees
21/05/2026 15:14
May 21 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: MARCH-QUARTER CONSOL NET PAT 9.21 BILLION RUPEES MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 88.53 BILLION RUPEES Source text: [ID:] Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11